Viewing Study NCT02541227


Ignite Creation Date: 2025-12-25 @ 5:11 AM
Ignite Modification Date: 2026-02-27 @ 3:14 AM
Study NCT ID: NCT02541227
Status: TERMINATED
Last Update Posted: 2022-04-06
First Post: 2015-08-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Cerebrolysin REGistry Study in Stroke
Sponsor: Ever Neuro Pharma GmbH
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module